119-HRES-803 DC Insider Whip Count Analysis
Bottom line: With Republicans holding a narrow House majority and leadership aligned with anti–abortion-pill messaging, H. Res. 803 is likely to pass if and when the Speaker brings it up, but margin depends on a handful of Biden‑district Republicans (e.g., Lawler, Fitzpatrick) and attendance amid the ongoing shutdown. Expect a largely party‑line vote; committee bottleneck is Energy & Commerce, and floor control rests with Rules and the Speaker. Confidence: moderate. [1]AP News — Republican Mike Johnson reelected House speaker in dramatic floor vote[2]Congress.gov (CRS) — Membership of the 119th Congress: A Profile[3]House Rules Committee (majority) — Chairwoman Foxx Opening Remarks on Rules' Or…[4]House Energy & Commerce Committee (majority) — Chairman Guthrie Announces House…
Breakdown: expected support/opposition
Institutional context: Republicans control the House in the 119th Congress with a slim, shifting margin; Mike Johnson was re‑elected Speaker on January 3, 2025. Floor time is tightly managed through the Rules Committee under Chair Virginia Foxx. Jurisdictionally, a resolution urging FDA action will sit in Energy & Commerce under Chair Brett Guthrie before leadership decides whether to mark it up or go straight to a special rule. [1]AP News — Republican Mike Johnson reelected House speaker in dramatic floor vote[2]Congress.gov (CRS) — Membership of the 119th Congress: A Profile[3]House Rules Committee (majority) — Chairwoman Foxx Opening Remarks on Rules' Or…[4]House Energy & Commerce Committee (majority) — Chairman Guthrie Announces House…
- Republicans: Broad support. The sponsor bloc and E&C Republicans have been pushing FDA to tighten or revisit mifepristone policies; Senate GOP just pressed HHS/FDA to reevaluate a newly approved generic. Expect most House Republicans to vote yes on a “reevaluate safety” message. [5]Office of Rep. John Rose — Rep. Rose on Supporting End of Abortion Drug By Mail[4]House Energy & Commerce Committee (majority) — Chairman Guthrie Announces House…[6]Office of Sen. Katie Britt — U.S. Senators Katie Britt, Lindsey Graham, Colleag…
- Democrats: Broad opposition. House Democratic leadership consistently frames medication abortion access as a priority and has backed resolutions affirming access; major medical groups (e.g., ACOG) continue to state mifepristone is safe and oppose added restrictions. Expect near‑uniform Democratic no. [7]Office of House Democratic Leader Hakeem Jeffries — Leader Jeffries: Three Year…[8]Congress.gov — Text – H. Res. 65 (119th): Reaffirming the freedom to decide and…[9]ACOG — Leading Medical Organizations Reaffirm the Safety of Mifepristone
- Independents/Delegates: No decisive bloc effect expected on a messaging resolution; outcome hinges on a handful of swing‑district Republicans and attendance. [2]Congress.gov (CRS) — Membership of the 119th Congress: A Profile
- Numbers: With an effective GOP edge in the low‑220s but frequent vacancies/absences, a party‑line rule and passage vote can clear with 217–218 present and voting. Base case: GOP yes in the 210–215 range; Dem yes at or near zero; outcome sensitive to 3–5 Biden‑district GOP defections or missed votes. [2]Congress.gov (CRS) — Membership of the 119th Congress: A Profile
Key legislators (pivotal swing votes)
Focus on Republicans from Biden‑won seats and/or members who have publicly broken with the party on abortion‑pill access.
| Member | Why pivotal | Read on their record/stance |
|---|---|---|
| Mike Lawler (R‑NY) | Publicly says he fought his own party to maintain access to mifepristone; likely no or abstain on a resolution framed as restricting access. | Member site states he “fought his own party to help maintain access to mifepristone.” [10]Office of Rep. Mike Lawler — Women’s Health – Rep. Mike Lawler position page |
| Brian Fitzpatrick (R‑PA) | Has urged caution on advancing restrictive abortion bills; moderate profile in a Biden‑won district; true toss‑up. | Said it’s “not wise” to push restrictive abortion bills; local coverage emphasizes his moderate positioning on abortion. [11]North Penn Now — Congressman Fitzpatrick: ‘I Don’t Think It’s Wise’ To Advance…[12]Web search · turn 14 #0 |
| David Valadao (R‑CA) | Biden‑district Republican who tends to avoid national‑ban framing; might follow leadership on a narrow “safety review” message; watch attendance. | Previously dodged national‑ban questions; emphasized state focus. [13]Web search · turn 15 #1 |
| Don Bacon (R‑NE) | Centrist; articulates a state‑centric posture; less likely to oppose a “review” resolution, but could balk if it’s seen as back‑door restriction. | States are the “center of gravity” on abortion; swing‑seat risk calculus applies. [13]Web search · turn 15 #1 |
| Diana Harshbarger (R‑TN) | E&C vice chair; has led House efforts to reverse Biden‑era mifepristone flexibilities; solid yes and potential caucus whip on this issue. | Reintroduced legislation to overturn Biden‑era FDA policy on mifepristone. [14]Web search · turn 18 #4 |
Leadership influence and procedural dynamics
This is a House‑only simple resolution. Passage hinges on majority leadership’s appetite to run a messaging vote and manage a tight margin.
- Speaker/majority: Speaker Mike Johnson controls floor timing; he’s pro‑life but has publicly downplayed prospects for a national ban, suggesting leadership will prefer messaging and oversight moves like H. Res. 803. Expect the Speaker to green‑light a floor vote when politically advantageous. [1]AP News — Republican Mike Johnson reelected House speaker in dramatic floor vote[15]The Washington Post — Johnson says he does not see national abortion ban next y…
- Rules Committee: Chair Virginia Foxx can report a closed rule to expedite floor action and contain amendments; with a narrow majority, leadership typically limits amendment exposure on polarizing social issues. [3]House Rules Committee (majority) — Chairwoman Foxx Opening Remarks on Rules' Or…
- Committee of referral: Energy & Commerce Chair Brett Guthrie can run a quick markup or allow leadership to bypass via a rule; E&C Republicans have been active on FDA/mifepristone oversight. [4]House Energy & Commerce Committee (majority) — Chairman Guthrie Announces House…
- Minority leadership: Hakeem Jeffries has anchored the caucus on protecting medication abortion access, making a whipped no vote likely. [7]Office of House Democratic Leader Hakeem Jeffries — Leader Jeffries: Three Year…
- External pressure: GOP senators’ letter urging HHS/FDA to reevaluate a newly approved generic mifepristone reinforces intra‑party pressure for a House vote; abortion‑rights groups and medical societies will press Democrats to oppose. [6]Office of Sen. Katie Britt — U.S. Senators Katie Britt, Lindsey Graham, Colleag…[9]ACOG — Leading Medical Organizations Reaffirm the Safety of Mifepristone
- Context/timing risk: The House has been in extended shutdown‑related recess; floor scheduling is fluid. If/when members return, leadership can drop this into a messaging block quickly via a structured rule. [16]AP News — Speaker Johnson keeps House lawmakers away, canceling another week's…
Assessment: likelihood of passage
What will happen, not what should happen.
Rationale: The issue salience inside the GOP conference is high (sponsor/signer momentum; Senate GOP letter), and the resolution’s text avoids a hard policy ban, making it easier for most Republicans to support. The gavel, Rules, and E&C are aligned. The only real exposure is a handful of Biden‑district Republicans (notably Lawler; Fitzpatrick uncertain) plus attendance during a volatile floor calendar. Net: moderate likelihood of passage on a mostly party‑line vote if leadership brings it up before year‑end. [5]Office of Rep. John Rose — Rep. Rose on Supporting End of Abortion Drug By Mail[6]Office of Sen. Katie Britt — U.S. Senators Katie Britt, Lindsey Graham, Colleag…[3]House Rules Committee (majority) — Chairwoman Foxx Opening Remarks on Rules' Or…[4]House Energy & Commerce Committee (majority) — Chairman Guthrie Announces House…[10]Office of Rep. Mike Lawler — Women’s Health – Rep. Mike Lawler position page[11]North Penn Now — Congressman Fitzpatrick: ‘I Don’t Think It’s Wise’ To Advance…
Sourcing (selected)
Key references underpinning whipcount, leadership control, caucus stances, and the regulatory backdrop.
- House control, margins, and Speaker election: AP and CRS profile of the 119th; Johnson re‑elected Speaker. [1]AP News — Republican Mike Johnson reelected House speaker in dramatic floor vote[2]Congress.gov (CRS) — Membership of the 119th Congress: A Profile
- Rules and E&C leadership/jurisdiction: official committee pages confirming Chair Foxx (Rules) and Chair Guthrie (E&C). [3]House Rules Committee (majority) — Chairwoman Foxx Opening Remarks on Rules' Or…[4]House Energy & Commerce Committee (majority) — Chairman Guthrie Announces House…
- Sponsor/House GOP posture on mifepristone: Rep. John Rose statement opposing mail‑order mifepristone; E&C GOP activity. [5]Office of Rep. John Rose — Rep. Rose on Supporting End of Abortion Drug By Mail[4]House Energy & Commerce Committee (majority) — Chairman Guthrie Announces House…
- Senate GOP pressure campaign: Letter urging reevaluation of the new generic. [6]Office of Sen. Katie Britt — U.S. Senators Katie Britt, Lindsey Graham, Colleag…
- Democratic leadership posture: Jeffries remarks backing reproductive freedom/medication abortion access; House Dem access resolution. [7]Office of House Democratic Leader Hakeem Jeffries — Leader Jeffries: Three Year…[8]Congress.gov — Text – H. Res. 65 (119th): Reaffirming the freedom to decide and…
- Medical community stance: ACOG statements reaffirming mifepristone safety. [9]ACOG — Leading Medical Organizations Reaffirm the Safety of Mifepristone
- Regulatory backdrop: Reports that FDA approved a new generic mifepristone in early October 2025. [18]Reuters — US FDA approves another generic version of abortion pill
- Swing‑vote evidence points: Lawler’s public position on mifepristone access; Fitzpatrick’s caution on further restrictions. [10]Office of Rep. Mike Lawler — Women’s Health – Rep. Mike Lawler position page[11]North Penn Now — Congressman Fitzpatrick: ‘I Don’t Think It’s Wise’ To Advance…
- SCOTUS context on mifepristone (standing, 2024): summary of FDA v. AHM decision. [19]Wired — Supreme Court Upholds Access to Abortion Pill in Unanimous Vote
- Calendar risk: ongoing shutdown‑related recess affecting House scheduling. [16]AP News — Speaker Johnson keeps House lawmakers away, canceling another week's…
- [1] Republican Mike Johnson reelected House speaker in dramatic floor vote AP News
- [2] Membership of the 119th Congress: A Profile Congress.gov (CRS)
- [3] Chairwoman Foxx Opening Remarks on Rules' Organizational Meeting House Rules Committee (majority)
- [4] Chairman Guthrie Announces House Committee on Energy and Commerce Full Committee Organizational Meeting for the 119th Congress House Energy & Commerce Committee (majority)
- [5] Rep. Rose on Supporting End of Abortion Drug By Mail Office of Rep. John Rose
- [6] U.S. Senators Katie Britt, Lindsey Graham, Colleagues Urge FDA to Reevaluate Generic Abortion Pill Approval Office of Sen. Katie Britt
- [7] Leader Jeffries: Three Years Since Dobbs – remarks on reproductive freedom Office of House Democratic Leader Hakeem Jeffries
- [8] Text – H. Res. 65 (119th): Reaffirming the freedom to decide and supporting medication abortion access Congress.gov
- [9] Leading Medical Organizations Reaffirm the Safety of Mifepristone ACOG
- [10] Women’s Health – Rep. Mike Lawler position page Office of Rep. Mike Lawler
- [11] Congressman Fitzpatrick: ‘I Don’t Think It’s Wise’ To Advance Restrictive Abortion Bills North Penn Now
- [12] Web search · turn 14 #0
- [13] Web search · turn 15 #1
- [14] Web search · turn 18 #4
- [15] Johnson says he does not see national abortion ban next year, even under Trump The Washington Post
- [16] Speaker Johnson keeps House lawmakers away, canceling another week's session as shutdown drags AP News
- [17] Web search · turn 9 #0
- [18] US FDA approves another generic version of abortion pill Reuters
- [19] Supreme Court Upholds Access to Abortion Pill in Unanimous Vote Wired
Discussion